Document and Entity Information
Document and Entity Information | Nov. 02, 2023 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Nov. 02, 2023 |
Entity Registrant Name | Mirum Pharmaceuticals, Inc. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-38981 |
Entity Tax Identification Number | 83-1281555 |
Entity Address, Address Line One | 950 Tower Lane |
Entity Address, Address Line Two | Suite 1050 |
Entity Address, City or Town | Foster City |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 94404 |
City Area Code | 650 |
Local Phone Number | 667-4085 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | true |
Entity Central Index Key | 0001759425 |
Title of 12(b) Security | Common stock, par value $0.0001 per share |
Trading Symbol | MIRM |
Security Exchange Name | NASDAQ |